Skip Navigation

European Heart Journal 2000 21(14):1113-1115; doi:10.1053/euhj.1999.2024
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rubins, H.B.
Right arrow Articles by Robins, S.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubins, H.B.
Right arrow Articles by Robins, S.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

The VA HDL Intervention Trial: clinical implications

H.B. Rubinsa, D. Collinsb and S.J. Robinsc

a Center for Chronic Disease Outcomes Research, Veterans Affairs Medical Center, Minneapolis, Minnesota, U.S.A.
b Department of Veterans Affairs Cooperative Studies Program Coordinating Center, West Haven, Connecticut, U.S.A.
c Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, U.S.A.

References

  1. Rubins HB, Robins SJ, Collins D. Distribution of lipids in 8,500 men with coronary artery disease. Am J Cardiol. 1995;75:1196–1201[CrossRef][Web of Science][Medline]
  2. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol. 1997;17:107–113[Abstract/Free Full Text]
  3. Rubins HB, Robins SJ, Iwane MK. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol an desirable low-density lipoprotein cholesterol. Am J Cardiol. 1993;71:45–52[CrossRef][Web of Science][Medline]
  4. Rubins HB, Robins SJ, Collins D. The Veterans Affairs High-Density Lipoprotein Intervention Trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Am J Cardiol. 1996;78:572–575[CrossRef][Web of Science][Medline]
  5. Rubins HB, Robins SJ, Collins D. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999;341:410–418[Abstract/Free Full Text]
  6. Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–1009[Abstract/Free Full Text]
  7. N Engl J Med. 1998;339:1349–1357[Abstract/Free Full Text]
  8. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–1109[Abstract/Free Full Text]
  9. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation. 1997;95:1–4[Free Full Text]
  10. Tenkanen L, Manttari M, Manninen V. Some coronary risk factors related to the insulin resistance syndrome and treatment with Gemfibrozil. Experience from the Helsinki Heart Study. Circulation. 1995;92:1779–1785[Abstract/Free Full Text]
  11. Schonfeld G. The effects of fibrates on lipoprotein and hemostatic coronary risk factors. Atherosclerosis. 1994;111:161–174[CrossRef][Web of Science][Medline]
  12. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart J-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088–2093[Abstract/Free Full Text]
  13. DiPalma JR, Thayer WS. Use of niacin as a drug. Annu Rev Nutr. 1991;11:169–187[CrossRef][Web of Science][Medline]
  14. Goldbourt U, Behar S, Reiss-Reicher H. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 1993;71:909–915[CrossRef][Web of Science][Medline]
  15. Grundy SM, Balady GJ, Criqui MH. When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on risk reduction. Circulation. 1997;95:1683–1685[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Fu, D. Mukhopadhyay, N. O. Davidson, and J. Borensztajn
The Peroxisome Proliferator-activated Receptor {alpha} (PPAR{alpha}) Agonist Ciprofibrate Inhibits Apolipoprotein B mRNA Editing in Low Density Lipoprotein Receptor-deficient Mice: EFFECTS ON PLASMA LIPOPROTEINS AND THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS
J. Biol. Chem., July 2, 2004; 279(27): 28662 - 28669.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. Vohnout
Letter to the Editor: Clinical implications of clinical studies: can we compare different subgroups defined a posteriori?
Eur. Heart J., May 1, 2001; 22(9): 798 - 798.
[PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rubins, H.B.
Right arrow Articles by Robins, S.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubins, H.B.
Right arrow Articles by Robins, S.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?